Clinuvel Pharmaceuticals (UR9) Income Statement

2 Followers

Clinuvel Pharmaceuticals Income Statement

Last quarter (Q4 2026), Clinuvel Pharmaceuticals 's total revenue was AU$57.09M, an increase of 3.10% from the same quarter last year. In Q4, Clinuvel Pharmaceuticals 's net income was AU$23.47M. See Clinuvel Pharmaceuticals ’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Jun 26	Jun 25	Jun 24	Jun 23	Jun 22
Total Revenue	AU$ 94.02M	AU$ 95.02M	AU$ 88.18M	AU$ 78.32M	AU$ 65.72M
Gross Profit	AU$ 78.21M	AU$ 79.14M	AU$ 80.45M	AU$ 50.59M	AU$ 46.62M
Operating Expenses	AU$ 37.68M	AU$ 33.40M	AU$ 31.30M	AU$ 9.68M	AU$ 13.53M
Depreciation and Amortization	AU$ 576.59K	AU$ 1.18M	AU$ 1.14M	AU$ 789.41K	AU$ 757.83K
EBITDA	AU$ 41.11M	AU$ 57.20M	AU$ 56.28M	AU$ 46.37M	AU$ 35.08M
Operating Income	AU$ 40.53M	AU$ 45.73M	AU$ 48.01M	AU$ 40.91M	AU$ 33.08M
Other Income/Expenses	AU$ 7.13M	AU$ 5.82M	AU$ 2.67M	AU$ 1.48M	AU$ -1.77M
Pretax Income	AU$ 47.66M	AU$ 51.55M	AU$ 50.68M	AU$ 45.58M	AU$ 34.32M
Net Income	AU$ 33.92M	AU$ 36.17M	AU$ 35.64M	AU$ 30.60M	AU$ 20.88M
Per Share Metrics
Basic EPS	AU$ 0.68	AU$ 0.72	AU$ 0.70	AU$ 0.62	AU$ 0.42
Diluted EPS	AU$ 0.68	AU$ 0.72	AU$ 0.70	AU$ 0.59	AU$ 0.40
Weighted Average Shares Outstanding	49.88M	50.08M	51.03M	49.41M	49.41M
Weighted Average Shares Outstanding (Diluted)	49.88M	50.38M	51.03M	51.82M	51.78M

Currency in AUD

Clinuvel Pharmaceuticals (UR9) Income Statement

Clinuvel Pharmaceuticals Income Statement

Clinuvel Pharmaceuticals Earnings and Revenue History